Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

835
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
835
Cross-bridge Cycle01:26

Cross-bridge Cycle

116.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.1K
Overview of Skeletal Muscle01:15

Overview of Skeletal Muscle

11.4K
Skeletal muscles are composed of a bundle of muscle fibers and are attached to bones through tendons. Each skeletal muscle fiber is a single muscle cell. The sarcolemma, the plasma membrane of a skeletal muscle cell, consists of a lipid bilayer and glycocalyx that supports muscle fibers. The sarcolemma extends into the muscle cells to form tubular structures called transverse or T-tubules. Each side of the T-tubules consists of a membrane-bound structure called the sarcoplasmic reticulum,...
11.4K
The Neuromuscular Junction01:19

The Neuromuscular Junction

9.0K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
9.0K
Microscopic Anatomy of Skeletal Muscles01:13

Microscopic Anatomy of Skeletal Muscles

12.6K
Skeletal muscle cells, also called muscle fibers, are distinctly elongated, multi-nucleated, slender biological units. They are packed with specialized structures designed to facilitate their primary function, which is contraction.
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...
12.6K
Chemical Synapses01:26

Chemical Synapses

8.6K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between COVID-19 Severity, Cognitive Impairment, and Quality of Life in Individuals in Need of Care: Results from the Multicentre Registry Study BaCoM.

Dementia and geriatric cognitive disorders extra·2026
Same author

Association of the phase angle with type 2 diabetes and related traits: results from two prospective KORA studies.

Nutrition & diabetes·2026
Same author

Expert Evaluation of the Perceived Accuracy, Relevance, and Safety of Large Language Model-Generated Patient Information in Geriatrics: Cross-Condition Study.

JMIR AI·2026
Same author

Oral health and oral health-related quality of life in community-dwelling older adults: associations with geriatric syndromes in a retrospective study.

Clinical oral investigations·2026
Same author

[The long lie fall : An overview of consequences, diagnostics and interventions].

Zeitschrift fur Gerontologie und Geriatrie·2026
Same author

The German simpler modified fried frailty scale: translation, cross-cultural adaptation and clinical validation.

BMC geriatrics·2026

Related Experiment Video

Updated: May 17, 2025

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography
07:33

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography

Published on: November 8, 2024

311

Neuromuscular sarcopenia: what do we know?

Michael Drey1

  • 1Department of Medicine IV, Geriatrics, LMU University Hospital, LMU Munich, Munich, Germany.

Current Opinion in Neurology
|May 16, 2025
PubMed
Summary

Neuromuscular sarcopenia, linked to agrin inactivation and neuromuscular junction instability, may soon have a biomarker. The neuronal C-terminal agrin fragment shows promise for diagnosing and potentially treating this geriatric condition.

Keywords:
C-terminal agrin fragmentagrindiagnosissarcopenia

More Related Videos

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

17.9K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
04:23

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

188

Related Experiment Videos

Last Updated: May 17, 2025

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography
07:33

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography

Published on: November 8, 2024

311
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

17.9K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
04:23

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

188

Area of Science:

  • Geriatric Medicine
  • Neuromuscular Biology
  • Biochemistry

Background:

  • Sarcopenia is a significant health issue in elderly patients.
  • Defining sarcopenia has evolved, shifting focus to treatable underlying mechanisms.
  • Geriatric care necessitates understanding and addressing sarcopenia's root causes.

Purpose of the Study:

  • To review the current understanding of sarcopenia definition and its pathomechanisms.
  • To explore neuromuscular sarcopenia, specifically focusing on the neuromuscular junction.
  • To identify potential biomarkers and therapeutic targets for sarcopenia subgroups.

Main Methods:

  • Literature review on sarcopenia definitions and pathomechanisms.
  • Analysis of the role of proteoglycan agrin in neuromuscular junction stability.
  • Investigation of the neuronal 22 kDa C-terminal agrin fragment as a potential biomarker.

Main Results:

  • Agrin plays a crucial role in clustering acetylcholine receptors at the neuromuscular junction.
  • Agrin inactivation destabilizes the neuromuscular junction, leading to sarcopenia.
  • The neuronal C-terminal agrin fragment is identified as a potential biomarker for neuromuscular sarcopenia.

Conclusions:

  • The neuronal C-terminal agrin fragment should be validated as a biomarker for neuromuscular sarcopenia.
  • Renal function must be considered due to fragment accumulation in renal insufficiency.
  • Targeted agrin treatment may offer a therapeutic strategy for this sarcopenia subgroup.